Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          Enter the terms you wish to search for.
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations                  
Office of the Assistant Secretary for Health
  About OASH
    
                        
                                            
      
      
      Public Health Offices
    
                        
                                            
      
      
      Advisory Committees

              

    



Breadcrumb
    HHS
                              ASH Home
                              Office of Science and Medicine
                              InnovationX


    

    

    Navigate to:
  Office of Science and Medicine
    
                                                  
                                                                  
            
      
      
      
      Chief Medical Officer
                                            
            
            Initiative on Substance Exposure in the Mother-Infant Dyad
    
                                                  
                                                                                        
                          
      
      
      
      InnovationX
                                            
            
            Covid-19 Data Driven Innovation
    
                                                                
                                                                  
            
      
      
      
      Human-Centered Design
                          
            
            Clinical Response through Emerging Technology (CRET)
    
                                                  
                                            
            
      
      
      
      Sickle Cell Disease
    
                                                  
                                            
            
      
      
      
      KidneyX
    
                                                                
                                                                  
            
      
      
      
      Lyme Innovation
                          
            
            Lyme Innovation: Real-World Impact
    
                                                  
                                            
            
      
      
      
      LymeX
    
                                                  
                                            
            
      
      
      
      PandemicX
    
                                                                
                                                                  
            
      
      
      
      Vector-Borne Disease National Strategy
                          
            
            Public Engagement
    
                                                  
                                            
            
      
      
      
      The Kay Hagan Tick Act
    
                                    
                                            
            
      
      
      
      LeadershipText resize icon

                    




InnovationX








  
  
    

  
      





HHS InnovationX forms coalitions and collaborations to tackle "wicked problems" with diverse stakeholders while leveraging resources from all sectors to accelerate innovation and scale solutions for real-world impact.

Our Methods
                        Data-Driven Innovation
    **Open Data:** Open data is information that may be freely used, re-used and redistributed by anyone — subject only, at most, to the requirement to attribute and share alike.
	**Open Science:** Open Science involves the free distribution of scientific research and facilitating access to science — often using distributed networks, new digital technologies, and collaborative tools.
	**Crowdsourcing:** Crowdsourcing is the practice of turning to a body of people to obtain needed knowledge, data, or information.
	Sprints: Structured, fast-paced, agile cycles of collaboration that accelerate the pace of digital innovation and technology development.
      Human-Centered Innovation
    **Customer Interviews and Ethnography:**Interviews with customers allow policymakers, program managers, and public health decision makers to get a glimpse into how “customers,” or people with lived experience with a health problem, interact with this issue, ultimately to drive new solutions and innovations.
	**Personas:** Personas are tools developed as a reference model that each represent a specific type of user, or behavioral archetype without expressing a defined personality or socio-demographic.
	**Journey Maps:**Journey maps are a synthesized step-by-step representation that describes how a user interacts with a health problem.
      Collaborative Innovation & Partnerships
    **Public-Private Partnerships:** Public-private partnerships involve collaboration between a government agency and a private-sector company that can be used to finance, build, and operate projects, or most commonly prize competitions.
	**Competitions, Prizes and Challenges:** HHS follows the America COMPETES Act authority and is able to carry out a program to award prizes competitively to stimulate innovation that has the potential to advance the health and human services of the country.
	**Accelerators:** Accelerators provide intensive and time-limited government, advisory and support for cohorts of startups, aiming to prepare them to advance towards solving necessary public health problems through innovative and disruptive solutions.
	**Citizen Science:**Citizen science is when the public participates voluntarily in the scientific process, addressing real-world problems in ways that may include formulating research questions, conducting scientific experiments, collecting and analyzing data, interpreting results, making new discoveries, developing technologies and applications, and solving complex problems.
	**Strategies & Collaboratives:**Collaborative innovation is a process by which multiple players contribute towards creating solutions, programs, policies, strategic directives and more with relevant and diverse stakeholders.
                        While the projects are ever-evolving to meet the new demands of the day, current focus is on data-driven approaches to infection-associated chronic conditions (e.g., Long COVID, Lyme disease, ME/CFS), vector-borne diseases, innovation to bridge wellness disparities and improve health equity, and public-private partnerships including CancerX, LymeX, KidneyX, and PandemicX.

Follow InnovationX on X (formerly Twitter) at @HHS_innovates

Kristen Honey, PhD PMP


Kristen T Honey, PhD, PMP

Chief Data Scientist
Kristen.Honey@hhs.govMeet the Chief Data Scientist
                        COVID-19 Data-Driven InnovationTools to drive innovation by making COVID-19 data more accessible.




Human-Centered DesignA program dedicated to unlocking new insights into health and health care challenges.
                        KidneyXA partnership between HHS and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.




Lyme InnovationAn initiative that harnesses the power of collaboration, open innovation, data-driven innovation, and emerging technologies for Lyme and tick-borne diseases.
                        PandemicXAn innovation accelerator using digital tools and public data to eliminate disparities exacerbated by COVID-19.




Vector-Borne Disease National StrategyIn response to the Kay Hagan Tick Act of 2019, the federal government has identified a plan to address vector-borne diseases.

                    
  


Content created by Assistant Secretary for Health (ASH) Content last reviewed January 25, 2024Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​